Salt and multiorgan damage in hypertension: Vascular stiffening and cardiorenal structural dysfunction responses

Blood Pressure and Arterial Wall Mechanics in Cardiovascular Diseases

Volumn 9781447151982, Issue , 2014, Pages 215-228

  Frohlich, Edward D ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Fibrosis; Heart; Heart failure; Inflammation; Kidneys; Large arteries; Local renin angiotensin systems; Reactive oxygen species; Renal failure; Salt

Indexed keywords

EID: 84949179683     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4471-5198-2_18     Document Type: Chapter

References (75)

1. Ambard L, Beaujard E. Causes de l'hypertension arterielle. Arch Gen Med. 1904;1:529.
2. Kurlansky M. SALT: a world history. New York: Penguin Books; 2002. p. 484.
3. Frohlich ED, Messerli FH. Sodium and hypertension. In: Papper S, editor. Sodium, Cations of biologic signifi cance, vol. 2. 2nd ed. Boca Raton: CRC Press; 1982. p. 144-74.
4. Frohlich ED. The salt conundrum: a hypothesis. Hypertension. 2007;50:161-6.
5. Frohlich ED. Are local renin-Angiotensin systems the focal points for understanding salt sensitivity in hypertension? In: Frohlich ED, Re RN, editors. The local cardiac renin-Angiotensin-Aldosterone system. 2nd ed. Federal Republic of Germany: Springer; 2009. p. 1-6.
6. Ferder LE. Renin angiotensin systems and aging. In: De Mello WC, Frohlich ED, editors. Renin angiotensin system and cardiovascular disease. New York: Humana Press; a part of Springer Science & Business Media, LLC; 2009. p. 231-43.
7. Frohlich ED, Susic D. Sodium and its multiorgan targets. Circulation. 2011;124:1882-5.
8. Rule AD, Hatem A, Conell LD, Taler SJ, Cosla FG, Kremers WK, Texter SC, Stegall MD. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med. 2010;152:561-7.
9. Seventh Report of the Joint National Committee on Prevention. Detection, evaluation, and treatment of high blood pressure (JNC-7). JAMA. 2003;289:2560-72.
10. International Society of Hypertension Writing Group. International Society of Hypertension (ISH), statement on blood pressure lowering and stroke prevention. J Hypertens. 2003;21:651-63.
11. Safar ME, Asmar RG, Benetos A, London GM, Levy BL. Sodium, large arteries and diuretic compounds in hypertension. J Hypertens. 1992;10:S133-6.
12. Safar ME, Thuilliez C, Richard V, Benetos A. Pressure independent contribution of sodium to large artery structure and function in hypertension. Cardiovasc Res. 2000;46:269-76.
13. Frohlich ED, Susic D. Pressure overload. Heart Fail Clin. 2012;8:21-32.
14. UK Food Standards Agency. Website. http://www. food.gov.uk . Accessed 18 June 2007.
15. Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RI, Seals DR, Sacks FM, Smith Jr. SC, Vafi adis DK, Van Horn LV. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation. 2011;123:1138-43.
16. Kotchen TA, Cowley Jr. AW, Frohlich ED. Salt in health and disease: a delicate balance. N Engl J Med. 2013;368:1229-37.
17. Smirk FH, Hall WH. Inherited hypertension in rats. Nature. 1958;182:717-28.
18. Trippodo NC, Frohlich ED. Controversies in cardiovascular research: similarities of genetic (spontaneous) hypertension. Man and rat. Circ Res. 1981;48:309-19.
19. Graham D, McBride MW, Gaasenbect M, Gilday K, Beattie E, Miller WH, McClure JD, Polke JM, Montezano A, Touyz RM, Dominiczak AF. Candidate genes that determine response to salt in the strokeprone spontaneously hypertensive rat. Congenic analysis. Hypertension. 2007;50:1134-41.
20. Smithies O. Turning pages (Nobel Lecture). Chembiochem. 2008;9:1342-2359.
21. Dahl LK. Effects of chronic excess salt feeding. Induction of self-sustaining hypertension in rats. J Exp Med. 1961;114:231-6.
22. Dahl LK, Heine M, Tassinari L. Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature. 1962;194:480-2.
23. Okomoto K, Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J. 1963;27:282-93.
24. Okamoto K, Tabei R, Fukkushima M, Nosaka S, Yamori Y, Ichijima K, Haebara H, Matsumoto M, Maruyama T, Suzuki Y, Tamegai M. Further observations of the development of a strain of spontaneously hypertensive rats. Jpn Circ J. 1966;30:703-16.
25. Aoki K, Yamori Y, Ooshima A, Okamoto K. Effects of high or low sodium intake in spontaneously hypertensive rats. Jpn Circ J. 1972;36:539-45.
26. Bianchi G, Baer PG, Fox U, Duzzi L, Pagetti D, Giovanetti AM. Changes in renin, water balance, and sodium balance during development of high blood pressure in genetically hypertensive rats. Circ Res. 1975;36/37(suppl I):153-61.
27. Pfeffer MA, Frohlich ED. Hemodynamic and myocardial function in young and old normotensive and spontaneously hypertensive rats. Circ Res. 1973;32(I):28-38.
28. Chrysant SG, Walsh GM, Frohlich ED. Hemodynamic changes induced by prolonged NaC1 and DOCA administration in spontaneously hypertensive rats (SHR). Angiology. 1978;29:303-9.
29. Chrysant SG, Walsh GM, Kem DC, Frohlich ED. Hemodynamic and metabolic evidence of salt sensitivity in spontaneously hypertensive rats. Am J Physiol. 1979;236:H403-8.
30. Sesoko S, Pegram BL, Wallis GW, Frohlich ED. DOCA-salt induced malignant hypertension in spontaneously hypertensive rats. J Hypertens. 1984;2: 49-54.
31. Frohlich ED, Chien Y, Sesoko S, Pegram BL. Relationships between dietary sodium intake, hemodynamics and cardiac mass in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Am J Physiol. 1993;264:R30-4.
32. Ahn J, Varagic J, Slama M, Susic D, Frohlich ED. Cardiac structural and functional responses to salt loading in SHR. Am J Physiol Heart Circ Physiol. 2004;287:H767-72.
33. Varagic J, Frohlich ED. Hypertension and the multifactorial role of salt. Lab Med. 2005;36:652-5.
34. Slama M, Ahn J, Peltier M, Maizel J, Chemla D, Varagic J, Susic D, Tribouilloy C, Frohlich ED. Validation of echocardiographic and Doppler indices of left ventricular relaxation in adult hypertensive and normotensive rats. Am J Physiol Heart Circ Physiol. 2005;289:H1131-6.
35. Varagic J, Frohlich ED, Diez J, Susic D, Ahn J, Gonzalez A, Lopez B. Myocardial fi brosis, impaired coronary hemodynamics, and biventricular dysfunction in salt-loaded SHR. Am J Physiol Heart Circ Physiol. 2006;290:H1503-9.
36. Matavelli LC, Zhou X, Varagic J, Susic D, Frohlich ED. Salt-loading produces severe renal hemodynamic dysfunction independent of arterial pressure in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2007;292:H814-9.
37. Varagic J, Frohlich ED, Susic D, Ahn J, Matavelli L, Lopez B, Diez J. AT1 receptor antagonism attenuates target organ effects of salt excess in SHRs without affecting pressure. Am J Physiol Heart Circ Physiol. 2008;294:H853-8.
38. Susic D, Zhou X, Frohlich ED. Angiotensin blockade prevents salt-induced injury of the renal circulation in spontaneously hypertensive rats. Am J Nephrol. 2009; 29:639-45.
39. Susic D, Varagic J, Frohlich ED. Cardiovascular effects of inhibition of renin-Angiotensin-Aldosterone system components in hypertensive rats given salt excess. Am J Physiol. 2010;298:H1177-81.
40. Susic D, Frohlich ED, Korori H, Shao W, Seth D, Navar LG. Salt-induced renal injury in SHR is mediated by AT1 receptor activation. J Hypertens. 2011;29: 716-23.
41. Susic D, Fares H, Frohlich ED. Nebivolol prevents myocardial fi brosis and diastolic dysfunction in saltloaded spontaneously hypertensive rats. J Am Soc Hypertens. 2012;6:316-23.
42. Susic D, Fares H, Frohlich ED. Telmisartan prevents salt-excess induced exacerbated (malignant) hypertension in spontaneously hypertensive rats. J Cardiovasc Pharmacol Ther. 2013;18:126-32.
43. Frohlich ED, Diez J. Left ventricular hypertrophy and treatment with renin angiotensin system inhibition. In: DeMello WC, Frohlich ED, editors. Renin angiotensin aldosterone system and cardiovascular disease. New York: Humana Press; 2009. p. 103-19.
44. Yu HCM, Burrel LM, Black J, Wu LL, Dilley RJ, Cooper ME, Johnston CI. Salt induces myocardium and renal fi brosis in normotensive and hypertensive rats. Circulation. 1998;98:2621-8.
45. Frohlich ED. Chapter 63: Evaluation and management of the patient with essential hypertension. In: Chatterjee K, Anderson M, Heistad D, Kerber R, editors. Cardiology-An illustrated text book, vol. 2. New Delhi: Jaypee Brothers Medical Pub. LTD; 2012. p. 1129-44.
46. Partovian C, Benetos A, Pommies JP, Mischler W, Safar ME. Effects of a chronic high-salt diet on large artery structure: role of endogenous bradykinin. Am J Physiol. 1998;274:H1423-8.
47. Labat C, Lacolley P, Lajemi M, deGaspero M, Safar ME, Benetos A. Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet. Hypertension. 2001;38:439-43.
48. Mercier N, Labat C, Louis H, Cattan V, Benetos A, Safar ME, Lacolley P. Sodium, arterial stiffness, and cardiovascular mortality in hypertensive rats. Am J Hypertens. 2007;20:319-25.
49. Stier Jr. CT, Chander P, Gutstein WH, Levine S, Itskovitz HD. Therapeutic benefit of captopril in saltloaded stroke-prone spontaneously hypertensive rats is independent of hypertensive effect. Am J Hypertens. 1991;3:680-7.
50. Kreutz R, Kovacevic L, Schulz A, Rothermund L, Ketteler M, Paul M. Effect of high NaC1 diet on spontaneously hypertension in a genetic rat model with reduced nephron number. J Hypertens. 2000;18:777-82.
51. duCaIlar G, Ribstein J, Mimran A. Dietary sodium intake and target organ damage in essential hypertension. Am J Hypertens. 2002;15:222-9.
52. Langenfeld MR, Schobel H, Veelken R, Weihprecht H, Schmieder RE. Impact of dietary sodium intake on left ventricular diastolic fi lling in early essential hypertension. Eur Heart J. 1998;19:951-8.
53. Williams JS, Solomon SD, Crivaro M, Colin PR. Dietary sodium intake modulates myocardial relaxation responsiveness to angiotensin II. Transl Res. 2006;48:49-54.
54. Hummel SL, Seymour M, Brook RD, Kollas TJ, Sheth SS, Rosenblum HR, Wells JM, Weder AB. Lowsodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction. Hypertension. 2012;60:1200-6.
55. Kalogeropoulous A, Georgiopouloa V, Psaty BM, Rodondi N, Smith AL, Harrison DG, Liu Y, Hoffmann U, Bauer DC, Neuman AB, Kritchevsky SB, Harris TB, Butler J. Infl ammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol. 2010;55:2129-37.
56. Feld LG, van Leiw JB, Brentjens JR, Boylan JW, Bemben S, Chang H, Manz N. Renal lesions and proteinuria in the spontaneously hypertensive rat model made normotensive by treatment. Kidney Int. 1981; 20:606-14.
57. Hirawa N, Uchara Y, Kawabata Y, Numabe A, Ogawa N, Gomi T, Ikeda T, Goto A, Toyo-oba T, Omata M. High-salt intake potentiates the renal vascular and glomerular damage caused by low doses of angiotensin II in uni-nephrectomized rats. J Hypertens. 1999; 17:923-32.
58. Inada Y, Tazawa S, Murakami M, Akahane M. KRH-594, a new angiotensin AT1 receptor antagonist, prevents end-organ damage in stroke-prone spontaneously hypertensive/Izm rats. Clin Exp Pharmacol Physiol. 2001;28:206-11.
59. Khalil RA. Dietary salt and hypertension: new molecular targets add more spice. Am J Physiol Regul Integr Comp Physiol. 2006;290:R509-13.
60. Price DA, Fisher NDL, Lansang MC, Stevanovic R, Williams GH, Hollenberg NK. Renal perfusion in blacks: alterations caused by insuppressibility of intrarenal renin with salt. Hypertension. 2002;40:186-9.
61. Verhave JC, Hillege HL, Burgerhof JGM, Janssen WMT, Gansevoort RT, Navis GJ, de Zeeuw D, Jong PE. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med. 2004;256:324-30.
62. Swift PA, Markandu ND, Sagnella GA, He FJ, MacGegor GA. Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial. Hypertension. 2005;46:308-16.
63. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev. 2005;85:679-715.
64. Schunkert H, Ingelfi nger JR, Jacob H, Jackson B, Bouyounes B, Dzau VJ. Reciprocal feedback regulation of kidney angiotensinogen and renin RNA expressions by angiotensin II. Am J Physiol. 1992;263:E863-9.
65. Kobori H, Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, Mamamoto T. Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens. 2008;2:349-54.
66. Kobori H, Alper B, Shenava R, Katsurada A, Saito T, Ohashi N, Urushihara M, Miyata K, Satoru R, Hamm L, Navar G. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-Angiotensin system in hypertensive patients. Hypertension. 2009;53(part 2): 344-50.
67. Kobori H, Urushhara M, Xu JH, Berenson GS, Navar LG. Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study). J Hypertens. 2010;28:1422-8.
68. Arita M, Horinaka S, Frohlich ED. Biochemical components and myocardial performance after reversal of left ventricular hypertrophy in spontaneously hypertensive rats. J Hypertens. 1993;11:951-9.
69. Lopez B, Quenejata R, Gonzalez A, Larman H, Diez J. Collagen cross-linking but not collagen amount associates with elevated fi lling pressures in hypertensive patients with stage C heart failure. Hypertension. 2013;60:677-83.
70. Pfeffer JM, Pfeffer MA, Braunwald E. Infl uence of chronic captopril therapy on the infarcted and left ventricle of the rat. Circ Res. 1985;57:84-95.
71. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown Jr. EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM, on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992;327: 669-77.
72. Pfeffer MA, Frohlich ED. Improvements in clinical outcomes with the use of angiotensin converting enzyme inhibitors: cross-fertilization between clinical and basic investigation. Am J Physiol Heart Circ Physiol. 2006;291:H2021-5.
73. Cook NR, Cutler JA, Obarzauck E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). Br Med J. 2007;334:885-8.
74. Page IH. Pathogenesis of arterial hypertension. JAMA. 1949;140:451-7.
75. Page IH. Arterial hypertension in retrospect. Circ Res. 1974;34:133-42.